医学
分级(工程)
一致性
前列腺癌
前列腺切除术
前列腺
直肠检查
H&E染色
病理
活检
数字化病理学
外科病理学
前列腺活检
癌症
内科学
染色
生物
生态学
作者
Okyaz Eminağa,Mahmoud Abbas,Christian A. Kunder,Yuri Tolkach,Ryan Han,James D. Brooks,Rosalie Nolley,Axel Semjonow,Martin Boegemann,Robert B. West,Jonathan Z. Long,Richard E. Fan,Olaf Bettendorf
标识
DOI:10.1038/s41598-024-55228-w
摘要
Abstract Prostate cancer pathology plays a crucial role in clinical management but is time-consuming. Artificial intelligence (AI) shows promise in detecting prostate cancer and grading patterns. We tested an AI-based digital twin of a pathologist, vPatho, on 2603 histological images of prostate tissue stained with hematoxylin and eosin. We analyzed various factors influencing tumor grade discordance between the vPatho system and six human pathologists. Our results demonstrated that vPatho achieved comparable performance in prostate cancer detection and tumor volume estimation, as reported in the literature. The concordance levels between vPatho and human pathologists were examined. Notably, moderate to substantial agreement was observed in identifying complementary histological features such as ductal, cribriform, nerve, blood vessel, and lymphocyte infiltration. However, concordance in tumor grading decreased when applied to prostatectomy specimens (κ = 0.44) compared to biopsy cores (κ = 0.70). Adjusting the decision threshold for the secondary Gleason pattern from 5 to 10% improved the concordance level between pathologists and vPatho for tumor grading on prostatectomy specimens (κ from 0.44 to 0.64). Potential causes of grade discordance included the vertical extent of tumors toward the prostate boundary and the proportions of slides with prostate cancer. Gleason pattern 4 was particularly associated with this population. Notably, the grade according to vPatho was not specific to any of the six pathologists involved in routine clinical grading. In conclusion, our study highlights the potential utility of AI in developing a digital twin for a pathologist. This approach can help uncover limitations in AI adoption and the practical application of the current grading system for prostate cancer pathology.
科研通智能强力驱动
Strongly Powered by AbleSci AI